You are a journalist looking for information about Synapsy, or about brain, mental illnesses, neuroscience, or psychiatry ?
Don’t hesitate to contact our Media Officer :
Yann Bernardinelli, PhD
- GliaPharm has set up home at Campus Biotech
A third “start-up” joins the Biotech Campus : GliaPharm, born at EPFL, tackles the disease of Stephen Hawking.
Tribune de Genève (PDF)
- What makes us social … or not
For the 19th edition of the Brain Awareness Week, various cities in Switzerland offer lectures, workshops, exhibitions or debates around the latest research on the brain. The opportunity for Sarah Dirren to take an interest in a double issue discussed in Lausanne on Thursday, March 16: what makes social humans … or not?
Elements of response with Claudia Bagni, the newly appointed director of the Department of Fundamental Neurosciences of the University of Lausanne (UNIL).
RTS radio, La Première – CQFD
- Pfizer Award 2017 to Alan Carleton (et al.)
Alan Carleton, Olivier Gschwend and Nixon Abraham are the happy beneficiaries of the 2017 Pfizer award in Neuroscience and Nervous System Illnesses. The three researchers are rewarded for their outstanding work entitled “Neuronal pattern separation in the olfactory bulb improves odor discrimination learning” and published in Nature Neurosciences.
- Decipher the emergence of neural diversity in the cerebral cortex
Alexandre Dayer and collaborators have analyzed the diversity of cortical neurons during the developmental period surrounding birth. They have discovered the emergence of three main subgroups of interneurons by decoding the expression of cell-type specific genes as well as their exact, and often unexpected, location in the cortex. To read in Nature Communication.
- The neuronal circuit of active and passive fear responses
Using in vivo optogenetics and extracellular recordings of identified cell types in a behavioral model in which mice switch between conditioned freezing and flight, Andreas Lüthi and collaborators have shown that active and passive fear responses are mediated by distinct and mutually inhibitory central amygdala neurons. The study was published in Nature.
- A center for brain rehabilitation
CHUV and the Institution of Lavigny join forces to better treat victims of strokes and cranio-cerebral trauma. “We aim to create the best conditions for researchers and clinicians to work together with an interdisciplinary spirit,” said Stephanie Clarke about the center.
- Cannabis: harmfulness and benefit
Legal consumption of cannabis remains controversial. It could be useful to treat diseases like multiple sclerosis or epilepsy but, on the other hand, it is responsible for many health problems like addiction. Christian Lüscher warn the audience of canal 9 TV about addiction problems.